Telomir Pharmaceuticals, Inc. (TELO)

NASDAQ: TELO · IEX Real-Time Price · USD

6.49

+0.47 (7.81%)

At close: May 9, 2024, 3:28 PM

6.70

+0.21 (3.24%)

After-hours: May 9, 2024, 4:18 PM EDT

Telomir Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	2.37	0.02	0.01
Research & Development	1.57	0.83	0.13
Operating Expenses	3.94	0.85	0.14
Operating Income	-3.94	-0.85	-0.14
Interest Expense / Income	1.64	0	0
Other Expense / Income	7.49	-	-
Pretax Income	-13.07	-0.85	-0.14
Net Income	-13.07	-0.85	-0.14
Shares Outstanding (Basic)	27	27	-
Shares Outstanding (Diluted)	29	27	-
Shares Change	8.16%	-	-
EPS (Basic)	-0.48	-0.03	-
EPS (Diluted)	-0.45	-0.03	-
Free Cash Flow	-3.86	-0.47	-0.12
Free Cash Flow Per Share	-0.14	-0.02	-
EBITDA	-11.43	-0.85	-0.14
EBIT	-11.43	-0.85	-0.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).